- · 《中国海洋药物》栏目设[09/30]
- · 《中国海洋药物》数据库[09/30]
- · 《中国海洋药物》收稿方[09/30]
- · 《中国海洋药物》投稿方[09/30]
- · 《中国海洋药物》征稿要[09/30]
- · 《中国海洋药物》刊物宗[09/30]
髋臼骨折固定后的异位骨化危险因素预防及其治(7)
作者:网站采编关键词:
摘要:[39] GHALAMBOR N, MATTA JM, BERNSTEIN L. Heterotopic ossification following operative treatment of acetabular fracture. An analysis of risk factors. Clin Orthop Relat Res. 1994;(305):96-105. [40] PENN
[39] GHALAMBOR N, MATTA JM, BERNSTEIN L. Heterotopic ossification following operative treatment of acetabular fracture. An analysis of risk factors. Clin Orthop Relat Res. 1994;(305):96-105.
[40] PENNAL GF, DAVIDSON J, GARSIDE H, et al. Results of treatment of acetabular fractures. Clin Orthop Relat Res. 1980;(151):115-123.
[41] ELHASSAN Y, ABDELHAQ A, PIGGOTT RP, et al. Heterotopic Ossification following acetabular fixation: Incidence and risk factors: 10-year experience of a tertiary centre. Injury. 2016;47(6):1332-1336.
[42] ANTHONISSEN J, STEFFEN CT, ALESSANDRI B, et al. Traumatic brain injury enhances the formation of heterotopic ossification around the hip: an animal model study [published online ahead of print, 2019 Dec 13]. Arch Orthop Trauma Surg. 2019;10.1007/s00402-019-03326-0.
[43] 邹重文,陆焱,黄智.吲哚美辛预防髋臼骨折术后异位骨化的疗效分析[J].中国矫形外科杂志,2017,25(10):870-873.
[44] SAGI HC, JORDAN CJ, BAREI DP, et al. Indomethacin prophylaxis for heterotopic ossification after acetabular fracture surgery increases the risk for nonunion of the posterior wall. J Orthop Trauma. 2014;28(7):377-383.
[45] RUO REDDA MG, DE COLLE C, BIANCO L, et al. Heterotopic ossifications: role of radiotherapy as prophylactic treatment. Radiol Med. 2018;123(6):463-468.
[46] MATTA JM, SIEBENROCK KA. Does indomethacin reduce heterotopic bone formation after operations for acetabular fractures? A prospective randomised study. J Bone Joint Surg Br. 1997;79(6):959-963.
[47] KARUNAKAR MA, SEN A, BOSSE MJ, et al. Indometacin as prophylaxis for heterotopic ossification after the operative treatment of fractures of the acetabulum. J Bone Joint Surg Br. 2006;88(12):1613-1617.
[48] RATH E, WARSCHAWSKI Y, MAMAN E, et al. Selective COX-2 Inhibitors Significantly Reduce the Occurrence of Heterotopic Ossification After Hip Arthroscopic Surgery. Am J Sports Med. 2016;44(3):677-681.
[49] CHENG L, LONG HT, SUN BH, et al. The efficacy of a multimodal analgesia protocol in preventing heterotopic ossification after acetabular fractures surgery. Int J Clin Pharm. 2017;39(4):826-830.
[50] MONTGOMERY T, PEARSON J, AGARWAL A, et al. Thrombin Hemostatic Matrix Reduces Heterotopic Ossification in Acetabular Fractures fixed via the Kocher-Langenbeck Approach [published online ahead of print, 2020 Apr 13]. J Orthop Trauma. 2020;10.1097/
[51] LEE DS, KIM Y, CHO HJ, et al. Hypofractionated Radiation Therapy for Progressive Heterotopic Ossification: The Relationship between Dose and Efficacy. Int J Radiat Oncol Biol Phys. 2020;106(5):993-997.
[52] ARCHDEACON MT, D’HEURLE A, NEMETH N, et al. Is preoperative radiation therapy as effective as postoperative radiation therapy for heterotopic ossification prevention in acetabular fractures? Clin Orthop Relat Res. 2014;472(11):3389-3394.
[53] MOURAD WF, PACKIANATHAN S, SHOURBAJI RA, et al. A prolonged time interval between trauma and prophylactic radiation therapy significantly increases the risk of heterotopic ossification. Int J Radiat Oncol Biol Phys. 2012;82(3):e339-e344.
[54] ROOS DE, SMITH JG. Radiotherapy for the prophylaxis of heterotopic ossification: A single 7-8Gy fraction seems optimal. Radiother Oncol. 2015;116(1):1-3.
[55] SHEYBANI A, TENNAPEL MJ, LACK WD, et al. Risk of radiation-induced malignancy with heterotopic ossification prophylaxis: a case-control analysis. Int J Radiat Oncol Biol Phys. 2014;89(3):584-589.
[56] 王一民,马云飞,姜楠,等.放射治疗与非甾体类抗炎药治疗预防髋部手术后异位骨化疗效比较的Meta 分析[J].中国全科医学, 2012,15(36):4200-4204.
[57] PIATEK S, WESTPHAL T, ARBTER D, et al. Wertigkeit einer kombinierten Ossifikationsprophylaxe mit Indometacin und Bestrahlung bei Azetabulumfrakturen [Value of a combined ossification prophylaxis with indomethacin and radiotherapy for acetabular fractures]. Unfallchirurg. 2006;109(7):556-562.
[58] WANG Q, YANG Q, ZHANG A, et al. Silencing of SPARC represses heterotopic ossification via inhibition of the MAPK signaling pathway. Biosci Rep. 2019;39(11):BSR.
[59] SORKIN M, HUBER AK, HWANG C, et al. Regulation of heterotopic ossification by monocytes in a mouse model of aberrant wound healing. Nat Commun. 2020;11(1):722.
[60] KUSANO T, NAKATANI M, ISHIGURO N, et al. Desloratadine inhibits heterotopic ossification by suppression of BMP2-Smad1/5/8 signaling [published online ahead of print, 2020 Feb 11]. J Orthop Res. 2020; 10.1002/jor..
[61] 张弛,纪方.SMAD7 调控内皮间质转化可预防跟腱损伤后的异位骨化[J].中国组织工程研究,2017,21(8):1178-1185.
[62] ZHANG Q, ZHANG Y, YAN M, et al. Bioinformatics Analysis of the Molecular Mechanism of Late-Stage Heterotopic Ossification. Biomed Res Int. 2020;2020:.
[63] SODEMANN B, PERSSON PE, NILSSON OS. Nonsteroid anti-inflammatory drugs prevent the recurrence of heterotopic ossification after excision. Arch Orthop Trauma Surg. 1990;109(2):53-56.
文章来源:《中国海洋药物》 网址: http://www.zghyywzzs.cn/qikandaodu/2021/0708/757.html